{"id":806178,"date":"2026-07-16T18:18:16","date_gmt":"2026-07-16T18:18:16","guid":{"rendered":"https:\/\/www.newsbeep.com\/ca\/806178\/"},"modified":"2026-07-16T18:18:16","modified_gmt":"2026-07-16T18:18:16","slug":"canadas-drug-agency-recommends-funding-treatment-for-early-stage-alzheimers-disease","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ca\/806178\/","title":{"rendered":"Canada&#8217;s Drug Agency recommends funding treatment for early-stage Alzheimer&#8217;s disease"},"content":{"rendered":"<p>Canada\u2019s Drug Agency is recommending that public drug plans pay for a treatment shown to slow the progression of early-stage Alzheimer\u2019s disease if patients meet certain conditions.<\/p>\n<p>Lecanemab is an antibody that targets the buildup of amyloid plaque in the brain, which is believed to be an underlying cause of the disease. <\/p>\n<p>Health Canada approved it last October, but Canada\u2019s drug agency recommended against publicly funding it in February due to concerns about effectiveness and possible side effects of brain swelling or bleeding. <\/p>\n<p>But after reconsidering at the request of the drug\u2019s manufacturer, Eisai, the agency\u2019s expert committee found it may have underestimated lecanemab\u2019s \u201cclinical meaningfulness.\u201d  <\/p>\n<p>In an updated recommendation released Thursday, the drug agency says it recognizes patients with early Alzheimer\u2019s disease \u201care faced with a progressive and ultimately debilitating condition for which there are limited treatment options.\u201d <\/p>\n<p>The agency says eligible patients must have only mild cognitive impairment, have amyloid protein confirmed by a brain scan or cerebrospinal fluid analysis and get regular MRI\u2019s to check for any signs of brain swelling or bleeding. <\/p>\n<p>\u201cThe committee discussed patient autonomy in making informed decisions about treatment in consultation with their health-care team regarding the potential benefits and risks,\u201d the recommendation says. <\/p>\n<p>If a patient\u2019s condition worsens from mild to moderate dementia, the drug should no longer be covered, it says. Studies have only shown lecanemab to be effective in early-stage Alzheimer\u2019s disease. <\/p>\n<p>Alzheimer\u2019s societies in Canada have been urging the drug agency and provincial governments to publicly fund lecanemab, also known by its brand name, Leqembi. <\/p>\n<p>They say the drug can extend the period of better cognitive function and give patients more quality time with loved ones before their dementia progresses.  <\/p>\n<p>Some dementia experts have said that the possible side effects of brain swelling or bleeding are usually minor and don\u2019t cause significant symptoms even though they\u2019re visible on MRI scans. <\/p>\n<p>According to the Canadian Consortium on Neurodegeneration in Aging, the cost of lecanemab is about $32,000 per year. <\/p>\n<p>It is given intravenously every two or four weeks, according to the consortium\u2019s website.<\/p>\n<p>\t\tKeep it Factual<\/p>\n<p>Add CityNews Toronto as a trusted source on Google to see more local stories from us.<\/p>\n<p>\t\t<a href=\"https:\/\/www.google.com\/preferences\/source?q=toronto.citynews.ca\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n\t\t<img loading=\"lazy\" decoding=\"async\" class=\"add-trusted-source-badge\" src=\"https:\/\/www.newsbeep.com\/ca\/wp-content\/uploads\/2026\/07\/google-trusted-badge.png\" alt=\"Add as a preferred source on Google\" width=\"198\" height=\"63\"\/><br \/>\n\t\t<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Canada\u2019s Drug Agency is recommending that public drug plans pay for a treatment shown to slow the progression&hellip;\n","protected":false},"author":2,"featured_media":806179,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[49,48,84,392,890,47,714],"class_list":["post-806178","post","type-post","status-publish","format-standard","has-post-thumbnail","category-healthcare","tag-ca","tag-canada","tag-health","tag-healthcare","tag-lifestyle","tag-national","tag-politics"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/806178","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/comments?post=806178"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/806178\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media\/806179"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media?parent=806178"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/categories?post=806178"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/tags?post=806178"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}